Teva Pharma and Alvotech Launch Biosimilar to J&J's Stelara in US

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson’s autoimmune drug Stelara in the United States, the second in a…
Reuters Health Information